Absence of universal programming framework and stable gut microbes limits living therapeutics
Synthetic biology endeavors to genetically reprogram microbes to perform beyond their inherent capabilities, allowing them to potentially function as diagnostic tools and living therapeutic devices or regulate a host’s immune system. In the case of the human microbiome, certain limitations to genetic editing exist, including the lack of a universal programming framework and organisms that are receptive to genetic manipulation. Microbes currently used in living therapeutics research have limited value due to their instability and inadequate presence in the human colon.
Universal transcriptional programming framework creates viable living therapeutics
This biotic decision-making technology uses genetic circuit compression in a Bacteroides community. The consortium-based transcriptional programming structure uses species of Bacteroides that have a significant, lasting presence in the human gut microbiome.
The programming framework demonstrates sequential gain-of-function control in a consortium of five distinct Bacteroides species using complete sets of logical operations. It confirms control in both heterologous and endogenous genes by coupling the transcription program with clustered regularly interspaced short palindromic repeats (CRISPR) interference. In addition, this new technology can be deployed in consortia to display concurrent, asymmetric, and sequential decision making.
Unlike Cello circuits, the current approach in gene circuit design, consortium transcriptional programming shortens circuit-building time, offers a compact circuit footprint that allows more complexity, uses fewer endogenous cellular resources, and reduces cell communication time in the Bacteroides community.
While this innovation still requires demonstration in a host or equivalent model system, it provides an outstanding foundation for the next generation of living therapeutics and an advanced platform to greatly enhance the study of the Bacteroides genus.
- Less expensive: Circuit compression decreases the resources needed to build and execute a program in a Bacteroides (chassis) cell.
- More advanced: Compression technology minimizes the genetic circuit footprint, allowing the creation of a higher complexity program.
- Flexible: The universality of this invention allows the writing of any program desired as long as the resource limits of the cell type are not exceeded.
- Adaptable: This technology may confer complex decision-making capabilities to consortia in other biotic systems.
This is a flexible platform technology with multiple applications in the biotechnology field, including:
- Living therapeutics
- Advanced biomanufacturing
- Next-generation biosecurity